Trans-NIH Research Support
Active
- Assistance listing
- 93.TNR
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Grant awards
- Not on record
Program facts
- Also known as
- NIH OD Research Support
- Treasury account
-
- 75-0846-0-1-552
- More information
Program details come from SAM.gov Assistance Listings. Updated .
About this program
The National Institutes of Health (NIH), through multiple offices in the Office of the Director and individual Institutes and Centers, funds research and research support activities via the Trans-NIH Research Support program (CFDA 93.TNR), which operates on an ad-hoc award cadence with no fixed application deadline or current open opportunity posted in the source.
The program funds research projects and supplements to existing awards across the NIH portfolio, with scope and priority determined by individual funding announcements from participating NIH offices and ICs. Eligible applicants include domestic and foreign organizations (where specified in individual initiatives), nonprofits, for-profits, universities, colleges, hospitals, laboratories, and individuals; some initiatives restrict eligibility to domestic applicants only.
Awards are predominantly Project Grants and Cooperative Agreements. Funding decisions rest on scientific merit and program relevance, evaluated through standard NIH peer review (scientific review group for merit, national advisory council or board for program fit). Review cycles run four to nine months.
The source provides no recent grant award portfolio data, award concentrations by funding IC, typical award magnitudes, or recent grant opportunities. The program description centers on policy, review procedures, audit requirements, and record retention (three years from annual financial status report submission) rather than recent funding activity or opportunity status.
Because the source contains only the Assistance Listing governance framework and lacks portfolio history, recent awards, or posted opportunities, a complete assessment of program activity level, typical funding ranges, and near-term pursuit timing is not supported. Contact the relevant NIH IC directly or monitor grants.nih.gov for current funding announcements to evaluate active solicitations.
Objective and description
- Objective
This listing covers multiple offices in the NIH Office of the Director and ICs at the NIH that offer assistance awards or supplements to assistance awards.
- Description
This listing covers multiple offices in the NIH Office of the Director and ICs at the NIH that offer assistance awards or supplements to assistance awards.
Eligibility
- Applicant eligibility
Awards can be made to domestic, public or private, for-profit or nonprofit organization, university, college, hospital, laboratory, or other institution, including State and local units of government, and individuals. Some initiatives will accept applications from foreign organizations. Additional details on eligibility are specified in each Funding Opportunity Announcement.
- Uses of assistance
To support research and other projects that will accelerate fundamental biomedical discovery and translation of that knowledge into effective prevention strategies and new treatments.
- Use restrictions
To support research and other projects that will accelerate fundamental biomedical discovery and translation of that knowledge into effective prevention strategies and new treatments.
How to apply
- Preapplication coordination
Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372.
- Criteria for selecting proposals
Funding decisions are based on scientific merit (42 CFR 52h) and program relevance. Scientific merit review encompasses: the peer review criteria detailed in the specific funding announcement, as well as the significance, approach, and innovation of the proposed research; the competency of the principal investigator; the adequacy of the resources and environment; the proposed budget and requested period of support; and, where applicable, the adequacy of the measures for protecting against adverse effects upon humans, animals, or the environment.
- Award procedure
Applications are reviewed for scientific and technical merit by a scientific review group and for program relevance by a national advisory council/board.
- Time to approval or disapproval
Not Applicable. The length of the review cycle is four to nine months.
- Appeals
Not Applicable. A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the NIH Scientific/Research contact, as provided on an initiative. A description of the NIH Peer Review Appeal procedures is available on the NIH Web site at http://grants.nih.gov/grants/guide/notice-files/not97-232.html .
Quick answers
What is Assistance Listing 93.TNR?
Assistance Listing 93.TNR is Trans-NIH Research Support, a federal grant program run by National Institutes of Health (Department of Health and Human Services).
What is the CFDA number for Trans-NIH Research Support?
Its CFDA number is 93.TNR: Assistance Listing numbers were called CFDA numbers before 2018.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program